Extended Data Table 1 Median age and interquartile range (IQR) at diagnosis in the absence and presence of pertinent germline findings

From: Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

  1. Statistical significance of pertinent germline finding for early tumor onset was calculated by Wilcoxon rank-sum test with Benjamini–Hochberg multiple testing. ***P < 0.0001, *P < 0.05. Tumor types without germline variant testing indicated in the NGTDC were excluded.